Creation of a versatile therapeutic platform using autologous gene-engineered B cell protein factories to make durable therapies for patients with genetic diseases
- Resource Type
- Abstract
- Source
- In
Molecular Genetics and Metabolism February 2024 141(2) - Subject
- Language
- ISSN
- 1096-7192